Glioblastoma multiforme market

Glioma and glioblastoma are both types of brain tumors, but they differ significantly in their characteristics and prognosis. Glioma is a broad term that encompasses tumors originating from glial cells, which are supportive cells in the brain. These tumors can vary in grade and aggressiveness, with some growing slo...

The present Glioblastoma multiforme (GBM) market has several unmet needs. Poor prognosis, 10-15 months median survival rate, no curative treatment to the patients, limited treatment options, drug resistance, incapability of therapies to cross BBB (blood-brain-barrier), intratumor heterogeneity, and a high mortality...

Headaches. Blurred vision. Nausea. No or poor appetite. Behavioral changes. Trouble thinking. These are some common problems people experience in their daily lives; however, are easy to write off as momentary or sideline in the name of stress. Yet, these constitute some of the common early symptoms of Glioblastoma ...